Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPA-15406 ointment in pediatric atopic dermatitis
jRCT2080223429Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of difamilast in atopic dermatitis (AD) (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT2080223429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223429.